These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9622042)

  • 1. Heparin-releasable endothelial cell-associated tissue factor pathway inhibitor (TFPI) is increased in the coronary circulation after coronary spasm in patients with coronary spastic angina.
    Nishiyama K; Ogawa H; Yasue H; Soejima H; Misumi K; Kugiyama K; Tsuji I; Kumeda K
    Thromb Res; 1998 Feb; 89(3):137-46. PubMed ID: 9622042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circadian variation in plasma levels of free-form tissue factor pathway inhibitor antigen in patients with coronary spastic angina.
    Misumi K; Ogawa H; Yasue H; Soejima H; Suefuji H; Nishiyama K; Takazoe K; Kugiyama K; Tsuji I; Kumeda K
    Jpn Circ J; 1998 Jun; 62(6):419-24. PubMed ID: 9652317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrinopeptide A is released into the coronary circulation after coronary spasm.
    Oshima S; Yasue H; Ogawa H; Okumura K; Matsuyama K
    Circulation; 1990 Dec; 82(6):2222-5. PubMed ID: 2146992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble P-selectin is released into the coronary circulation after coronary spasm.
    Kaikita K; Ogawa H; Yasue H; Sakamoto T; Suefuji H; Sumida H; Okumura K
    Circulation; 1995 Oct; 92(7):1726-30. PubMed ID: 7545553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet-derived growth factor is released into the coronary circulation after coronary spasm.
    Ogawa H; Yasue H; Okumura K; Fujii H; Masuda T; Miyao Y; Bannai S; Takanashi N
    Coron Artery Dis; 1993 May; 4(5):437-42. PubMed ID: 8261220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased plasma level of endothelin-1-like immunoreactivity during coronary spasm in patients with coronary spastic angina.
    Matsuyama K; Yasue H; Okumura K; Saito Y; Nakao K; Shirakami G; Imura H
    Am J Cardiol; 1991 Oct; 68(10):991-5. PubMed ID: 1927939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parameters of the tissue factor pathway with coumadin/dipyridamole versus ticlopidine as adjunct antithrombotic-drug regimen in coronary artery stenting.
    Kopp CW; Steiner S; Priglinger U; Christ G; Probst P; Maurer G; Minar E; Huber K
    Blood Coagul Fibrinolysis; 2003 Jun; 14(4):379-86. PubMed ID: 12945880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of tissue factor pathway inhibitor in the coronary circulation of patients with acute coronary syndromes.
    Golino P; Ravera A; Ragni M; Cirillo P; Piro O; Chiariello M
    Circulation; 2003 Dec; 108(23):2864-9. PubMed ID: 14656922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increase in plasma levels of secretory type II phospholipase A(2) in patients with coronary spastic angina.
    Kugiyama K; Ota Y; Kawano H; Soejima H; Ogawa H; Sugiyama S; Doi H; Yasue H
    Cardiovasc Res; 2000 Jul; 47(1):159-65. PubMed ID: 10869542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced platelet aggregation in the coronary circulation after coronary spasm.
    Miyamoto S; Ogawa H; Soejima H; Takazoe K; Kajiwara I; Shimomura H; Sakamoto T; Yoshimura M; Kugiyama K; Yasue H; Ozaki Y
    Thromb Res; 2001 Sep; 103(5):377-86. PubMed ID: 11553370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin C attenuates abnormal vasomotor reactivity in spasm coronary arteries in patients with coronary spastic angina.
    Kugiyama K; Motoyama T; Hirashima O; Ohgushi M; Soejima H; Misumi K; Kawano H; Miyao Y; Yoshimura M; Ogawa H; Matsumura T; Sugiyama S; Yasue H
    J Am Coll Cardiol; 1998 Jul; 32(1):103-9. PubMed ID: 9669256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma tissue factor pathway inhibitor and tissue factor antigen levels after administration of heparin in patients with angina pectoris.
    Soejima H; Ogawa H; Yasue H; Nishiyama K; Kaikita K; Misumi K; Takazoe K; Kugiyama K; Tsuji I; Kumeda K; Nakamura S
    Thromb Res; 1999 Jan; 93(1):17-25. PubMed ID: 10065895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial dysfunction and coronary artery spasm.
    Kawano H; Ogawa H
    Curr Drug Targets Cardiovasc Haematol Disord; 2004 Mar; 4(1):23-33. PubMed ID: 15032650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consumption of vitamin E in coronary circulation in patients with variant angina.
    Miwa K; Igawa A; Nakagawa K; Hirai T; Inoue H
    Cardiovasc Res; 1999 Jan; 41(1):291-8. PubMed ID: 10325977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin-releasable and platelet pools of tissue factor pathway inhibitor in rabbits.
    Warn-Cramer BJ; Maki SL; Rapaport SI
    Thromb Haemost; 1993 Mar; 69(3):221-6. PubMed ID: 8470044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aerobic interval exercise training in the afternoon reduces attacks of coronary spastic angina in conjunction with improvement in endothelial function, oxidative stress, and inflammation.
    Morikawa Y; Mizuno Y; Harada E; Katoh D; Kashiwagi Y; Morita S; Yoshimura M; Uemura S; Saito Y; Yasue H
    Coron Artery Dis; 2013 May; 24(3):177-82. PubMed ID: 23249633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acetylcholine-induced coronary spasm in patients with unobstructed coronary arteries is associated with elevated concentrations of soluble CD40 ligand and high-sensitivity C-reactive protein.
    Ong P; Carro A; Athanasiadis A; Borgulya G; Schäufele T; Ratge D; Gaze D; Sechtem U; Kaski JC
    Coron Artery Dis; 2015 Mar; 26(2):126-32. PubMed ID: 25405929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelium-dependent dilator response to substance P in patients with coronary spastic angina.
    Okumura K; Yasue H; Ishizaka H; Ogawa H; Fujii H; Yoshimura M
    J Am Coll Cardiol; 1992 Oct; 20(4):838-44. PubMed ID: 1382082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levels of heparin-releasable TFPI are increased in first-ever lacunar stroke patients.
    Knottnerus IL; Winckers K; Ten Cate H; Hackeng TM; Lodder J; Rouhl RP; Staals J; Govers-Riemslag JW; Bekers O; van Oostenbrugge RJ
    Neurology; 2012 Feb; 78(7):493-8. PubMed ID: 22302552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue factor pathway inhibitor (TFPI) antigen plasma level in patients with interstitial lung disease before and after heparin administration.
    Cella G; Cipriani A; Tommasini A; Rampin E; Sbarai A; Rocconi R; Mazzaro G; Luzzatto G
    Semin Thromb Hemost; 1997; 23(1):45-9. PubMed ID: 9156410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.